Summit Therapeutics (SMMT) Prepaid Assets (2018 - 2026)
Summit Therapeutics (SMMT) posted quarterly Prepaid Assets of $29.6 million for Q2 2026, up 167.74% year-on-year from $11.0 million in Q2 2025, and up 68.55% on a QoQ basis from $17.6 million in Q1 2026.
Summit Therapeutics (SMMT) Prepaid Assets (2018 - 2026) Analysis & Trends
Summit Therapeutics (SMMT) has reported Prepaid Assets for 9 consecutive years, with $29.6 million the latest figure, recorded in Q2 2026.
- Quarterly Prepaid Assets rose 167.74% year-over-year to $29.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $29.6 million (up 167.74% YoY) and the FY2025 annual result came in at $6.5 million, down 40.98% from the prior year.
- Prepaid Assets climbed to $29.6 million in Q2 2026 per SMMT's latest filing, from $17.6 million in the prior quarter.
- Over the last five years, Prepaid Assets for SMMT reached as high as $29.6 million in Q2 2026 and fell as low as $1.2 million in Q1 2023.
- A 5-year average of $7.2 million and a median of $5.4 million in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets sank 80.71% — and 2025, when it surged 438.45%.
- Year by year, Prepaid Assets stood at $1.5 million in 2022, then surged by 74.34% to $2.6 million in 2023, then jumped by 322.43% to $11.1 million in 2024, then tumbled by 40.98% to $6.5 million in 2025, then jumped by 352.55% to $29.6 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $29.6 million, $17.6 million, and $6.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Summit Therapeutics | 11.62 Bn | 11.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.58 Mn |
| Mar 31, 2026 | 17.55 Mn |
| Dec 31, 2025 | 6.54 Mn |
| Sep 30, 2025 | 7.59 Mn |
| Jun 30, 2025 | 11.05 Mn |
| Mar 31, 2025 | 9.12 Mn |
| Dec 31, 2024 | 11.08 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Jun 30, 2024 | 2.05 Mn |
| Mar 31, 2024 | 5.32 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Sep 30, 2023 | 5.07 Mn |
| Jun 30, 2023 | 6.09 Mn |
| Mar 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | 1.62 Mn |
| Jun 30, 2022 | 5.39 Mn |
| Mar 31, 2022 | 4.35 Mn |
| Dec 31, 2021 | 7.16 Mn |
| Sep 30, 2021 | 8.41 Mn |